20/20 Biolabs, Inc.
AIDX
$0.60
$0.011.58%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 311.22% | -10.39% | 11.82% | -42.61% | 0.00% |
| Total Receivables | 0.75% | 46.09% | -21.46% | -- | -- |
| Inventory | -10.07% | 112.04% | -11.18% | -- | -- |
| Prepaid Expenses | 35.81% | -43.74% | 49.97% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 219.51% | -6.05% | 10.83% | -- | -- |
|
|
|||||
| Total Current Assets | 219.51% | -6.05% | 10.83% | -- | -- |
| Net Property, Plant & Equipment | -8.20% | -7.80% | -7.31% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -0.23% | -1.33% | -1.34% | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -98.49% | 221.75% | 1,959.74% | -- | -- |
| Total Assets | 40.26% | 27.72% | 20.12% | -- | -- |
|
|
|||||
| Total Accounts Payable | 12.90% | 38.21% | 12.90% | -- | -- |
| Total Accrued Expenses | -16.96% | 30.62% | 11.95% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 98.08% | 44.60% | 1.46% | -- | -- |
| Total Finance Division Other Current Liabilities | -19.27% | -5.18% | 54.74% | -- | -- |
| Total Other Current Liabilities | -19.27% | -5.18% | 54.74% | -- | -- |
| Total Current Liabilities | 4.75% | 23.64% | 21.08% | -- | -- |
|
|
|||||
| Total Current Liabilities | 4.75% | 23.64% | 21.08% | -- | -- |
| Long-Term Debt | -- | 37.49% | 528.31% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -12.20% | -8.82% | -7.95% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -93.66% | 284.12% | 232.75% | -- | -- |
| Total Liabilities | -26.71% | 32.76% | 33.51% | -- | -- |
|
|
|||||
| Common Stock & APIC | 14.45% | 3.69% | 3.25% | -- | -- |
| Retained Earnings | -6.54% | -4.09% | -4.07% | -- | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 3,944.73% | -208.32% | -79.86% | -79.13% | 0.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 332.63% | 0.00% | 0.00% | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 332.63% | 0.00% | 0.00% | 0.85% | 0.00% |
|
|
|||||
| Total Common Equity | 3,944.73% | -208.32% | -79.86% | -79.13% | 0.00% |
| Total Preferred Equity | 332.63% | 0.00% | 0.00% | 0.85% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 14,459.90% | -117.70% | -69.14% | -76.65% | 0.00% |
|
|
|||||